| Application number | Title of the application | Filing Date | Status |
|---|
| 09/637681 | Methods and compositions for diagnosis of hepatoma | Aug 13, 2000 | Abandoned |
Array
(
[id] => 7612640
[patent_doc_number] => 06903195
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Methods and compositions for detecting CDN apoptosis-modulating proteins'
[patent_app_type] => utility
[patent_app_number] => 09/633200
[patent_app_country] => US
[patent_app_date] => 2000-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 7560
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903195.pdf
[firstpage_image] =>[orig_patent_app_number] => 09633200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/633200 | Methods and compositions for detecting CDN apoptosis-modulating proteins | Aug 6, 2000 | Issued |
Array
(
[id] => 1246230
[patent_doc_number] => 06677428
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Mammaglobin, a secreted mammary-specific breast cancer protein'
[patent_app_type] => B1
[patent_app_number] => 09/509015
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 12627
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677428.pdf
[firstpage_image] =>[orig_patent_app_number] => 09509015
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509015 | Mammaglobin, a secreted mammary-specific breast cancer protein | May 29, 2000 | Issued |
Array
(
[id] => 6711002
[patent_doc_number] => 20030170751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Immunohistochemical assay for ras activity'
[patent_app_type] => new
[patent_app_number] => 09/569197
[patent_app_country] => US
[patent_app_date] => 2000-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09569197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/569197 | Immunohistochemical assay for ras activity | May 10, 2000 | Abandoned |
| 09/403075 | MEKK1 PROTEINS AND FRAGMENTS THEREOF FOR USE IN REGULATING APOPTOSIS | May 9, 2000 | Abandoned |
| 09/566441 | Urokinase plasminogen activator receptor as a target for diagnosis of metastases | May 7, 2000 | Abandoned |
Array
(
[id] => 848891
[patent_doc_number] => 07381407
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-06-03
[patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen'
[patent_app_type] => utility
[patent_app_number] => 09/561462
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 16317
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381407.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561462
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561462 | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen | Apr 27, 2000 | Issued |
Array
(
[id] => 655191
[patent_doc_number] => 07109301
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-19
[patent_title] => 'Tenascin-C isoform as marker for neoplasias'
[patent_app_type] => utility
[patent_app_number] => 09/959373
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 6
[patent_no_of_words] => 2804
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959373
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959373 | Tenascin-C isoform as marker for neoplasias | Apr 18, 2000 | Issued |
| 09/509779 | SAG: SENSITIVE TO APOPTOSIS GENE | Mar 28, 2000 | Abandoned |
Array
(
[id] => 676444
[patent_doc_number] => 07087712
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-08
[patent_title] => 'Peptide for triggering an immune reaction against tumor cells'
[patent_app_type] => utility
[patent_app_number] => 10/019513
[patent_app_country] => US
[patent_app_date] => 2000-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4128
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10019513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/019513 | Peptide for triggering an immune reaction against tumor cells | Mar 27, 2000 | Issued |
Array
(
[id] => 1204627
[patent_doc_number] => 06716426
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => 'Antitumor agents'
[patent_app_type] => B1
[patent_app_number] => 09/536017
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3857
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716426.pdf
[firstpage_image] =>[orig_patent_app_number] => 09536017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/536017 | Antitumor agents | Mar 26, 2000 | Issued |
| 09/402845 | COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST TUMOR-RELATED ANTIGENS | Mar 13, 2000 | Abandoned |
Array
(
[id] => 6740729
[patent_doc_number] => 20030158098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Colon specific gene and protein'
[patent_app_type] => new
[patent_app_number] => 09/525041
[patent_app_country] => US
[patent_app_date] => 2000-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14582
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158098.pdf
[firstpage_image] =>[orig_patent_app_number] => 09525041
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/525041 | Colon specific gene and protein | Mar 13, 2000 | Issued |
Array
(
[id] => 1334776
[patent_doc_number] => 06596849
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules'
[patent_app_type] => B1
[patent_app_number] => 09/520255
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 17615
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596849.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520255
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520255 | Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules | Mar 6, 2000 | Issued |
Array
(
[id] => 1224616
[patent_doc_number] => 06699980
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/514768
[patent_app_country] => US
[patent_app_date] => 2000-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 30
[patent_no_of_words] => 20524
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699980.pdf
[firstpage_image] =>[orig_patent_app_number] => 09514768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/514768 | Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof | Feb 27, 2000 | Issued |
| 09/512435 | Treatment regimen for prostate cancer | Feb 24, 2000 | Abandoned |
Array
(
[id] => 5801469
[patent_doc_number] => 20020009755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'ALTERNATIVE SPLICING OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 MRNA IN PROSTATE CANCER'
[patent_app_type] => new
[patent_app_number] => 09/465802
[patent_app_country] => US
[patent_app_date] => 1999-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9839
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009755.pdf
[firstpage_image] =>[orig_patent_app_number] => 09465802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465802 | ALTERNATIVE SPLICING OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 MRNA IN PROSTATE CANCER | Dec 16, 1999 | Abandoned |
Array
(
[id] => 1501518
[patent_doc_number] => 06486300
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'Human nm23-like protein'
[patent_app_type] => B1
[patent_app_number] => 09/460532
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17927
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/486/06486300.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460532
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460532 | Human nm23-like protein | Dec 12, 1999 | Issued |
| 09/454595 | METHODS OF IDENTIFYING POTENTIALLY THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC AGENTS WITH VIABLE CULTURED CELLS HAVING AN INTACT CELL MEMBRANE AND PRODUCT BT SAME | Dec 6, 1999 | Abandoned |
Array
(
[id] => 742010
[patent_doc_number] => 07030232
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'E25A protein, methods for producing and use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/451214
[patent_app_country] => US
[patent_app_date] => 1999-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14894
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030232.pdf
[firstpage_image] =>[orig_patent_app_number] => 09451214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/451214 | E25A protein, methods for producing and use thereof | Nov 28, 1999 | Issued |